Cargando…

Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field

Trophic factors control cellular physiology by activating specific receptor tyrosine kinases (RTKs). While the over activation of RTK signaling pathways is associated with cell growth and cancer, recent findings support the concept that impaired down-regulation or deactivation of RTKs may also be a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ledda, Fernanda, Paratcha, Gustavo
Formato: Texto
Lenguaje:English
Publicado: Libertas Academica 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717834/
https://www.ncbi.nlm.nih.gov/pubmed/19662191
_version_ 1782169923579019264
author Ledda, Fernanda
Paratcha, Gustavo
author_facet Ledda, Fernanda
Paratcha, Gustavo
author_sort Ledda, Fernanda
collection PubMed
description Trophic factors control cellular physiology by activating specific receptor tyrosine kinases (RTKs). While the over activation of RTK signaling pathways is associated with cell growth and cancer, recent findings support the concept that impaired down-regulation or deactivation of RTKs may also be a mechanism involved in tumor formation. Under this perspective, the molecular determinants of RTK signaling inhibition may act as tumor-suppressor genes and have a potential role as tumor markers to monitor and predict disease progression. Here, we review the current understanding of the physiological mechanisms that attenuate RTK signaling and discuss evidence that implicates deregulation of these events in cancer.
format Text
id pubmed-2717834
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Libertas Academica
record_format MEDLINE/PubMed
spelling pubmed-27178342009-08-06 Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field Ledda, Fernanda Paratcha, Gustavo Biomark Insights Review Trophic factors control cellular physiology by activating specific receptor tyrosine kinases (RTKs). While the over activation of RTK signaling pathways is associated with cell growth and cancer, recent findings support the concept that impaired down-regulation or deactivation of RTKs may also be a mechanism involved in tumor formation. Under this perspective, the molecular determinants of RTK signaling inhibition may act as tumor-suppressor genes and have a potential role as tumor markers to monitor and predict disease progression. Here, we review the current understanding of the physiological mechanisms that attenuate RTK signaling and discuss evidence that implicates deregulation of these events in cancer. Libertas Academica 2007-02-14 /pmc/articles/PMC2717834/ /pubmed/19662191 Text en © 2007 by the authors http://creativecommons.org/licenses/by/3.0 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Ledda, Fernanda
Paratcha, Gustavo
Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field
title Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field
title_full Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field
title_fullStr Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field
title_full_unstemmed Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field
title_short Negative Regulation of Receptor Tyrosine Kinase (RTK) Signaling: A Developing Field
title_sort negative regulation of receptor tyrosine kinase (rtk) signaling: a developing field
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717834/
https://www.ncbi.nlm.nih.gov/pubmed/19662191
work_keys_str_mv AT leddafernanda negativeregulationofreceptortyrosinekinasertksignalingadevelopingfield
AT paratchagustavo negativeregulationofreceptortyrosinekinasertksignalingadevelopingfield